WASHINGTON, June 19 (Reuters) - Home Diagnostics Inc., which makes supplies for diabetics, on Monday set its planned initial public offering at 6.6 million shares for between $14 and $16 per share.
WASHINGTON, June 19 (Reuters) - Home Diagnostics Inc., which makes supplies for diabetics, on Monday set its planned initial public offering at 6.6 million shares for between $14 and $16 per share.